WebJun 7, 2024 · With 3.5 years of follow-up to the phase 3 KEYNOTE-426 trial (NCT02853331), frontline treatment of renal cell carcinoma (RCC) with the combination of pembrolizumab (Keytruda) plus axitinib (Inlyta) led to a survival benefit over sunitinib (Sutent), according to a presentation of the results at the 2024 American Society of Clinical Oncology (ASCO) … WebInlyta Axitinib 5 Mg Tablets, Pfizer, 14'S. ₹ 65,000/ BOX Get Latest Price. Packaging Size: 14'S. Brand: INLYTA. Composition: AXITINIB. Manufacturer: Pfizer. Treatment: Axitinib is used in combination with avelumab (Bavencio) or pembrolizumab (Keytruda) to treat advanc. Prescription/Non prescription: Prescription.
HIGHLIGHTS OF PRESCRIBING INFORMATION Gastrointestinal …
WebFeb 20, 2024 · Inlyta is a brand-name prescription drug. It’s approved for use in certain adults with renal cell carcinoma (RCC), which is a type of kidney cancer.RCC can occur … WebPatient Assistance Program. Pfizer Oncology Together. 877-744-5675. What type of drug is it?: Targeted therapy (also referred to as a tyrosine kinase inhibitor or TKI). How is it prescribed?: Axitinib is approved to be used alone (as a single agent) or in combination with pembrolizumab (Keytruda) or avelumab (Bavencio). evington road leicester map
Inlyta Tablet - Latest Price, Dealers & Retailers in India - IndiaMART
WebThe Opadry II red 32K15441 film coating contains: lactose monohydrate, HPMC 2910/Hypromellose 15cP, titanium dioxide, triacetin (glycerol triacetate), and red iron oxide. LAB-0439-7.0. For more information, go to www.inlyta.com or call 8770744-5675. This product's labeling may have been updated. WebAxitinib (Inlyta ®) is a targeted therapy drug used to treat a type of kidney cancer called renal cell carcinoma that has spread outside of the kidney.This is called advanced or metastatic kidney cancer. It is best to read this information with our general information about targeted therapy and kidney cancer.. Axitinib is a type of treatment called a tyrosine kinase inhibitor … WebSep 3, 2012 · Vous trouverez les indications thérapeutiques de ce médicament dans le paragraphe 4.1 du RCP ou dans le paragraphe 1 de la notice. Ces documents sont disponibles en cliquant ici. Groupe(s) générique(s) Ce médicament appartient au(x) groupe(s) générique(s) suivants : AXITINIB 1 mg - INLYTA 1 mg, comprimé pelliculé broyeur de pierre clash of clan